돌아가기
Huagongshe화공사 화학 정보 인쇄 보고서 · 연구 참고용
HRID 659754생성일: 2026년 10월 23일

Piperazine Dihydrochloride → Irbesartan

https://huagongshe.com/ko/reaction/659754

반응식

참여 물질

역할이름HCID투입량
반응물Piperazine DihydrochlorideHCID 8893—
반응물Sodium AzideHCID 33557—
반응물4'-((2-Butyl-4-oxo-1,3-diazaspiro(4.4)non-1-ene-3-yl)methyl)(1,1'-biphenyl)-2-carbonitrileHCID 9843116—
용매O-XyleneHCID 7237—
생성물IrbesartanHCID 374996%

반응 단계

A mixture of 2-n-butyl-3-[(2′-cyanobiphenyl-4-yl)methyl]-1,3-diazaspiro-[4,4]-non-1-en-4-one (10 g), sodium azide (7.7 g) and piperazine dihydrochloride (7.5 g) in xylene (30 ml) was refluxed for 7 hours under stirring. The reaction was cooled to room temperature and extracted with 5% NaOH solution. The pooled alkaline solution was washed with toluene or xylene (15 ml) and the aqueous phase neutralized to pH 6.5 using concentrated HCL. The resulting suspension was stirred for 3 hours at room temperature and filtered obtain irbesartan (3.6 g, 96% purity by HPLC).

출처 및 근거

DOI10.6084/m9.figshare.5104873.v1
특허 번호US08080670B2
출처 데이터셋uspto-grants-2011_12
ORD IDord-a67296b3abe540c4a17ddd7e7fd19fb6
출처 메모uspto-grants-2011_12